• Latest Posts

These Biotech Veterans have Launched a Startup to ‘Drug the Undruggable’

Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

Heptares’ G-Protein StaR Platform has now Hooked Pfizer in a Billion Euro Deal

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

A reliable technology to develop the next generation of GPCR targeted medicines


A $500 Million Deal to Reactivate T-cells’ Anti-cancer Response

MorphoSys Tackles the Technical Challenge of GPCR-targeted Drugs